Clinical Trial Update: Acetylcarnitine and Insulin Sensitivity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated acetylcarnitine for improving insulin sensitivity in Type 2 Diabetes Mellitus. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Acetylcarnitine (acetylcarnitine)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED